Veana Therapeutics, Inc. — Form D
Veana Therapeutics, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-13. The offering totals $1.3M, of which $831K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-11-13
- Form: D
- Accession: 0001461859-20-000027
- Industry: Pharmaceuticals
- Exemptions: 04, 06b
- Total offering: $1.3M
- Amount sold: $831K
- Remaining: $434K
- Investors: 4
- Date of first sale: 2020-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380485
Issuer
- Name: Veana Therapeutics, Inc.
- CIK: 0001741217
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 9398 SW WASHINGTON STREET, PORTLAND, OR, 97225
- Phone: (503) 292-4065
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| EMMANUEL AKPORIAYE | Director | Portland, OR |
| REBECCA AKPORIAYE | Director | Portland, OR |
| BRUCE RAMSEYER | Director | Portland, OR |
| Andrew Ray | Director | Baltimore, MD |
| Sandra Shotwell | Director | Portland, OR |
| EMMANUEL AKPORIAYE | Executive Officer | Portland, OR |
| REBECCA AKPORIAYE | Executive Officer | Portland, OR |
| EMMANUEL AKPORIAYE | Promoter | Portland, OR |
| F Andrew Ray | Director | Portland, OR |
| Mark F Holifer | Director | Portland, OR |
| Mark F Holifer | Executive Officer | Portland, OR |
| Mark F Holifer | Promoter | Portland, OR |
| Rebecca F Akporiaye | Director | Portland, OR |
| Rebecca F Akporiaye | Executive Officer | Portland, OR |
| Andrew D Thaler | Executive Officer | Portland, OR |
| Denis R Burger | Director | Portland, OR |
| Thomas E McChesney | Executive Officer | Portland, OR |
| Trent D Davis | Director | Portland, OR |
Other filings by this issuer (1)
More